Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

BACKGROUND: The role of combination immunomodulatory therapy with systemic corticosteroids and tocilizumab (TCZ) for aged patients with COVID-19-associated cytokine release syndrome remains unclear. METHODS: A retrospective single-center study was conducted on consecutive patients aged ≥65 years who...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Medrano, Francisco, Pérez-Jacoiste Asín, María Asunción, Fernández-Ruiz, Mario, Carretero, Octavio, Lalueza, Antonio, Maestro de la Calle, Guillermo, Caro, José Manuel, de la Calle, Cristina, Catalán, Mercedes, García-García, Rocío, Martínez-López, Joaquín, Origüen, Julia, Ripoll, Mar, San Juan, Rafael, Trujillo, Hernando, Sevillano, Ángel, Gutiérrez, Eduardo, de Miguel, Borja, Aguilar, Fernando, Gómez, Carlos, Silva, José Tiago, García-Ruiz de Morales, Daniel, Saro-Buendía, Miguel, Marrero-Sánchez, Ángel, Chiara-Graciani, Guillermo, Bueno, Héctor, Paz-Artal, Estela, Lumbreras, Carlos, Pablos, José L., Aguado, José María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908857/
https://www.ncbi.nlm.nih.gov/pubmed/33647515
http://dx.doi.org/10.1016/j.ijid.2021.02.099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908857/
https://www.ncbi.nlm.nih.gov/pubmed/33647515
http://dx.doi.org/10.1016/j.ijid.2021.02.099

Ejemplares similares